Published in Gene Therapy Weekly, January 15th, 2004
According to published research from Finland, "magnetic resonance imaging relaxation times, T-1rho and Carr-Purcell T-2 (CP-T-2), were measured in a glioma herpes simplex virus-thymidine kinase gene therapy model."
"In treated tumors with >50% cell death by histology, T-1rho and CP-T-2 measured with short spacing (tau(CP)) between centers of adiabatic refocusing pulses showed similar enhanced sensitivity to cytotoxic cell damage over CP-T2 measured with long tau(CP) (long-tau(CP) T-2: 54.3±0."7 and 55.4±1.2 ms, p=0.30; short-tau(CP) T-2: 61.3±1.0 and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.